Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
- PMID: 36835904
- PMCID: PMC9958625
- DOI: 10.3390/jcm12041368
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
Abstract
Hemophilia A (HA) is an inherited X-linked bleeding disorder, caused by the deficiency of coagulation factor VIII (FVIII), with variable clinical phenotypes [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?Ital J Pediatr. 2020 Sep 14;46(1):129. doi: 10.1186/s13052-020-00878-5. Ital J Pediatr. 2020. PMID: 32928254 Free PMC article.
-
Congenital hemophilia A with low activity of factor XII: a case report and literature review.Ital J Pediatr. 2021 Oct 11;47(1):204. doi: 10.1186/s13052-021-01137-x. Ital J Pediatr. 2021. PMID: 34635150 Free PMC article. Review.
-
Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches?J Blood Med. 2017 Jun 15;8:67-73. doi: 10.2147/JBM.S103796. eCollection 2017. J Blood Med. 2017. PMID: 28670147 Free PMC article. Review.
-
Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.Methods Mol Biol. 2017;1646:265-276. doi: 10.1007/978-1-4939-7196-1_21. Methods Mol Biol. 2017. PMID: 28804835
-
Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice.J Clin Med. 2022 Jun 10;11(12):3345. doi: 10.3390/jcm11123345. J Clin Med. 2022. PMID: 35743412 Free PMC article.
Cited by
-
Emerging Therapies in Hemophilia: Improving Equitable Access to Care.J Blood Med. 2025 Feb 20;16:95-115. doi: 10.2147/JBM.S490588. eCollection 2025. J Blood Med. 2025. PMID: 39995897 Free PMC article. Review.
-
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.Hemasphere. 2025 Mar 25;9(3):e70111. doi: 10.1002/hem3.70111. eCollection 2025 Mar. Hemasphere. 2025. PMID: 40134524 Free PMC article.
-
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes.Semin Thromb Hemost. 2025 Feb;51(1):58-67. doi: 10.1055/s-0044-1786358. Epub 2024 May 11. Semin Thromb Hemost. 2025. PMID: 38733982 Free PMC article. Review.
-
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial.Res Pract Thromb Haemost. 2024 Nov 29;9(1):102648. doi: 10.1016/j.rpth.2024.102648. eCollection 2025 Jan. Res Pract Thromb Haemost. 2024. PMID: 39810986 Free PMC article.
-
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia.Mol Diagn Ther. 2024 May;28(3):239-248. doi: 10.1007/s40291-024-00705-1. Epub 2024 Mar 28. Mol Diagn Ther. 2024. PMID: 38538969 Free PMC article. Review.
References
-
- White G.C., 2nd, Rosendaal F., Aledort L.M., Lusher J.M., Rothschild C., Ingerslev J., Factor VIII and Factor IX Subcommittee Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb. Haemost. 2001;85:560. - PubMed
-
- Mancuso M.E., Bidlingmaier C., Mahlangu J.N., Carcao M., Tosetto A., Subcommittee on Factor VIII’ Factor IX and Rare Coagulation Disorders The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: Communication from the SSC of ISTH. J. Thromb. Haemost. 2018;16:2106–2110. doi: 10.1111/jth.14257. - DOI - PubMed
-
- Di Minno M.N.D., Ambrosino P., Franchini M., Coppola A., Di Minno G. Arthropathy in Patients with Moderate Hemophilia A: A Systematic Review of the Literature. Semin. Thromb. Hemost. 2013;39:723–731. - PubMed